Telix Files Form 20-F Registration Statement for Nasdaq ADS
![]() |
MELBOURNE, Australia, Oct. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) relating to a proposed listing of American Depository Shares (ADS),...
Read more: Telix Files Form 20-F Registration Statement for Nasdaq ADS





